The FTC Says Martin Shkreli Traded Shares in at Least 60 Drug Companies Despite a Lifetime Ban. It Wants His Profits, With No Offset for Losses.
The Federal Trade Commission and seven states asked a federal judge in Manhattan on Tuesday 13 October to hold Martin Shkreli in civil contempt of the 2022 order banning him from the pharmaceutical industry for life. They allege he has traded shares in more than 60 drug companies since leaving prison and promoted short positions on livestreams. The court has not ruled, and no response from Shkreli or his lawyers had been reported.



